These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1964216)

  • 21. Combined dexamethasone and human chorionic gonadotropin in diagnosis of polycystic ovarian disease.
    Beck WW; McEvoy D; Wallach EE
    Obstet Gynecol; 1971 Feb; 37(2):211-7. PubMed ID: 5539356
    [No Abstract]   [Full Text] [Related]  

  • 22. [The Stein-Leventhal syndrome with obesity].
    Stankusheva T; Balabanski L; Popova D; Boiadzhieva P
    Akush Ginekol (Sofiia); 1989; 28(3):52-4. PubMed ID: 2802082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism.
    Rossi R; Tauchmanovà L; Luciano A; Valentino R; Savastano S; Battista C; Di Martino M; Lombardi G
    J Endocrinol Invest; 2001; 24(7):491-8. PubMed ID: 11508782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents.
    Villarroel C; López P; Merino PM; Iñiguez G; Sir-Petermann T; Codner E
    Gynecol Endocrinol; 2015; 31(8):625-9. PubMed ID: 26190534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation and treatment of adolescent girls with hirsutism].
    Bumbuliene Z; Alisauskas J
    Ginekol Pol; 2009 May; 80(5):374-8. PubMed ID: 19548458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between buserelin and dexamethasone testing in the assessment of hirsutism.
    Re T; Barbetta L; Dall'Asta C; Faglia G; Ambrosi B
    J Endocrinol Invest; 2002 Jan; 25(1):84-90. PubMed ID: 11883870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of acute ACTH1-24 loading on the steroid hormone and prolactin content of the blood serum in women with hyperprolactinemia and hyperandrogenism].
    Dedov II; Mel'nichenko GA; Bol'shakova TD; Buniatian AF; Gitel' EP; Shilin DE; Nosova AA
    Probl Endokrinol (Mosk); 1990; 36(5):43-9. PubMed ID: 2080142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.
    Lucky AW; Rosenfield RL; McGuire J; Rudy S; Helke J
    J Clin Endocrinol Metab; 1986 May; 62(5):840-8. PubMed ID: 3007557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women.
    Rittmaster RS; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1985 Sep; 61(3):462-6. PubMed ID: 2991319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.
    Pang SY; Lerner AJ; Stoner E; Levine LS; Oberfield SE; Engel I; New MI
    J Clin Endocrinol Metab; 1985 Mar; 60(3):428-39. PubMed ID: 2982896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women.
    Ansarin H; Aziz-Jalali MH; Rasi A; Soltani-Arabshahi R
    Arch Iran Med; 2007 Jan; 10(1):7-13. PubMed ID: 17198446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hirsutism: implications, etiology, and management.
    Hatch R; Rosenfield RL; Kim MH; Tredway D
    Am J Obstet Gynecol; 1981 Aug; 140(7):815-30. PubMed ID: 7258262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating androgens in hirsutism.
    Khandekar S; Lata V; Dash RJ
    J Assoc Physicians India; 1989 Oct; 37(10):632-5. PubMed ID: 2632509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical practice. Hirsutism.
    Rosenfield RL
    N Engl J Med; 2005 Dec; 353(24):2578-88. PubMed ID: 16354894
    [No Abstract]   [Full Text] [Related]  

  • 35. Hirsutism and hyperandrogenism.
    Givens JR
    Adv Intern Med; 1976; 21():221-47. PubMed ID: 130060
    [No Abstract]   [Full Text] [Related]  

  • 36. The clinical evaluation of hirsutism.
    Somani N; Harrison S; Bergfeld WF
    Dermatol Ther; 2008; 21(5):376-91. PubMed ID: 18844715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
    Siegel SF; Finegold DN; Lanes R; Lee PA
    N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of synthetic gonadotropin releasing hormone on the plasma levels of FH and LSH in women with hirsutism and polycystic ovaries].
    Pjević M; Kovac T; Bujas M; Pusac R
    Jugosl Ginekol Perinatol; 1985; 25(3-4):49-52. PubMed ID: 3938829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Routine screening for Cushing's syndrome is not required in patients presenting with hirsutism.
    Karaca Z; Acmaz B; Acmaz G; Tanriverdi F; Unluhizarci K; Aribas S; Sahin Y; Kelestimur F
    Eur J Endocrinol; 2013 Mar; 168(3):379-84. PubMed ID: 23221034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hirsutism and virilism in women.
    Kirschner MA
    Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.